These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7341286)

  • 21. The cellular immortalization process: relevant issues for the generation of cell substrates for production of vaccines and other biologicals.
    Sedivy JM
    Dev Biol (Basel); 2001; 106():479-86; discussion 486-8, 501-11. PubMed ID: 11761263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Best animal care practices in the production and control of biologicals.
    Morton DB; Hanenberg E; Hogg A; Priebel Valera G; Lund C; Ottiger HP; Gorska P; Borensztejn C; Pereira S; Bousrih M; Blumrich M; Chapek ML; Ramirez A; Thuring J; Umiza A
    Dev Biol (Basel); 2002; 111():221-5. PubMed ID: 12678246
    [No Abstract]   [Full Text] [Related]  

  • 23. Quality of biotechnological products: derivation and characterisation of cell substrates used for production of biotechnological/biological products. ICH Harmonised Tripartite Guideline.
    Dev Biol Stand; 1998; 93():223-34. PubMed ID: 9737399
    [No Abstract]   [Full Text] [Related]  

  • 24. Genetic stability and product consistency of rDNA-derived biologicals from mammalian cells.
    Bebbington CR; Lambert K
    Dev Biol Stand; 1994; 83():183-4. PubMed ID: 7883094
    [No Abstract]   [Full Text] [Related]  

  • 25. International Conference on Harmonisation; guidance on quality of biotechnological/biological products: derivation and characterization of cell substrates used for production of biotechnological/biological products; availability. Notice. Food and Drug Administration, HHS.
    Fed Regist; 1998 Sep; 63(182):50244-9. PubMed ID: 12269373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Administration of tumor cell chromatin to immunosuppressed and non-immunosuppressed non-human primates.
    Wierenga DE; Cogan J; Petricciani JC
    Biologicals; 1995 Sep; 23(3):221-4. PubMed ID: 8527121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WHO Expert Committee on biological standardization.
    World Health Organ Tech Rep Ser; 2007; (941):1-340, back cover. PubMed ID: 18314862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction in animal use in the production and testing of biologicals.
    Festing MF
    Dev Biol Stand; 1999; 101():195-200. PubMed ID: 10566793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of biological products prepared from mammalian cell culture. Karyology.
    Dev Biol Stand; 1998; 93():134-6. PubMed ID: 9737392
    [No Abstract]   [Full Text] [Related]  

  • 30. An overview of quantitative PCR assays for biologicals: quality and safety evaluation.
    Xu Y; Brorson K
    Dev Biol (Basel); 2003; 113():89-98. PubMed ID: 14620857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autologous biologicals--science/regulations.
    Chapek ML; Brown KK; Lin BC
    Dev Biol (Basel); 2004; 117():33-41. PubMed ID: 15597614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of biological products prepared from mammalian cell culture. Bovine spongiform encephalopathy and other non-viral transmissible agents.
    Dev Biol Stand; 1998; 93():133-4. PubMed ID: 9737391
    [No Abstract]   [Full Text] [Related]  

  • 33. Safety of biological products prepared from mammalian cell culture. Host-cell proteins.
    Dev Biol Stand; 1998; 93():139-40. PubMed ID: 9737394
    [No Abstract]   [Full Text] [Related]  

  • 34. Risk assessment on the carcinogenic potential of hybridoma cell DNA: implications for residual contaminating cellular DNA in biological products.
    Dortant PM; Claassen IJ; van Kreyl CF; van Steenis G; Wester PW
    Biologicals; 1997 Dec; 25(4):381-90. PubMed ID: 9467034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of biological products prepared from mammalian cell culture. Testing source materials.
    Dev Biol Stand; 1998; 93():131-3. PubMed ID: 9737390
    [No Abstract]   [Full Text] [Related]  

  • 36. Regulation of veterinary biological products for fish in the United States.
    Birnbaum NG
    Dev Biol Stand; 1997; 90():335-40. PubMed ID: 9270861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of biological products prepared from mammalian cell culture. DNA.
    Dev Biol Stand; 1998; 93():136-8. PubMed ID: 9737393
    [No Abstract]   [Full Text] [Related]  

  • 38. Safety of biological products prepared from mammalian cell culture. Detecting viruses in cell banks.
    Dev Biol Stand; 1998; 93():129. PubMed ID: 9737388
    [No Abstract]   [Full Text] [Related]  

  • 39. Safety of biological products prepared from mammalian cell culture. In-process testing for viral agents.
    Dev Biol Stand; 1998; 93():130-1. PubMed ID: 9737389
    [No Abstract]   [Full Text] [Related]  

  • 40. Appropriate mammalian expression systems for biopharmaceuticals.
    Werner RG; Noé W; Kopp K; Schlüter M
    Arzneimittelforschung; 1998 Aug; 48(8):870-80. PubMed ID: 9748718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.